Composition for treatmet of cartilage disease comprising a monovalent metal salt of alginic acid and bone marrow mesenchymal stem cells

• 收藏
• 分享

专利权人:

LIMITED;MOCHIDA PHARMACEUTICAL CO., LIMITED;NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY;MOCHIDA PHARMACEUTICAL CO.

发明人:

IWASAKI, NORIMASA,MINAMI, AKIO,KASAHARA, YASUHIKO,IGARASHI, TATSUYA,KAWAMURA, DAISUKE,KASAHARA, FUMIYOSHI,MIYAJIMA, CHIHIRO,OHZAWA, NOBUO,IMAI, MARIKO

申请号：

NZ59610508

公开号：

NZ596105A

申请日:

2008.02.21

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

The use of a composition that has a low endotoxin monovalent metal salt of alginic acid having a molecular weight of 500,000 or more and a bone marrow mesenchymal stem cell for treating a cartilage injury. The composition has a viscosity of 400 millipascal-second to 20,000 millipascal-second. The monovalent metal salt of alginic acid can be sodium alginate or potassium alginate and the composition can be cured at the site of injury with the application of calcium chloride.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/